Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 August 2021 | Story Ruan Bruwer | Photo Roger Sedres (Gallo Images)
Louzanne Coetzee and her guide Estean Badenhorst won the silver medal in the 1 500 m in a new African time at the Paralympics in Tokyo on Monday.

It’s been eight years of waiting, but Louzanne Coetzee will finally hang a medal around her neck, and this on the biggest sporting stage in the world.

Coetzee won the silver medal in the 1 500 m women’s T11 final at the Paralympics in Tokyo on Monday (30 August 2021) morning. In the process, she and her guide, Estean Badenhorst, set a new African record (4:40.96).

They are both former University of the Free State (UFS) students, and Coetzee is a resident on the Bloemfontein Campus. 

“I have been competing for eight years and this is my first medal. I’m just overwhelmed. I couldn’t have asked for a better race, a better guide, and better preparation. I’m just very thankful for how everything went down,” Coetzee said.
The race took place at 32 degrees with a humidity percentage of 70 plus. Coetzee’s time was only 2.04 seconds off the previous world record. 

She has had a stunning Games so far. In Sunday’s heat, she improved her personal best from 4:51.65 to 4:49.24 and ran another eight seconds quicker on Monday.

It was also a personal triumph for Coetzee, who experienced the disappointment of being disqualified five years ago at the Rio Games, after a ruling that her guide had stepped in front of her. 

Prof Francis Petersen, UFS Rector and Vice-Chancellor, saluted Coetzee. “We are tremendously proud of what she has achieved throughout her athletics career. She has represented the country numerous times at international sport events and winning a silver medal and setting a new African record is the culmination of hard work and exceptional endurance.” 

“The entire university community was rooting for her; she has done us and her country extremely proud,” Prof Petersen said.

Coetzee still has the T12 marathon on Sunday on her schedule.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept